»

[spacepenguin]

Phooey, I missed this.

[blue]

I would only put in limit orders for the day. I didn't mean a good until cancelled order when i said limit order - just because you tend to forget that you have good til cancelled orders in and then one day in the far future they may get triggered and you forgot and didn't keep the cash around for it, so suddenly you are on margin or have used up cash in your account that you wanted for something else. (the margin comment is assuming you have a margin account). And I never specified 50 cents in particular. I just meant that this stock will probably drift down toward that again after all this news from conferences is over, based on what has happened before, and you can get it cheaper. So don't chase it on a move like this one, that is based on temporary publicity and what ifs and not real news about a new approval. My point was that the big payoff is not around the corner--it's when they get approval for their main product here--the oral insulin that they are already selling in other countries, so there is time to get in at a better price.

[blue]

Originally Posted by genxeratl Well I made the mistake of selling this one when it hit 0.50 - patience is not my best virtue. I had been holding it FOREVER and got tired of watching it just roll around. Big mistake. Anyone think it will pull back enough to get back in or did I really screw this one up?

i have been holding it forever as well. I think you will get another chance. It's already back to 75 cents today after getting above one (1.14 actually) with over 71 million shares traded. This is just a quick up and down, like many another. Who knows, maybe you can pick up some more for 30 or 40 cents in a few weeks. With this stock you have to have a lot of patience, and try to buy low. I've seen analyst estimates of 6 bucks (for what it's worth, maybe not a whole lot)--but that assumes, I think, that they finally get FDA approval for oral lyn first.....

[fherrada]

Originally Posted by victoria Can someone please explain a limit order? This means that your buy is only triggered at that price, or is there more to it? Does a long standing limit buy placed below the current price-as Blue recommends, does this tie up funds until it is triggered? Anyone's overview explaining how limit orders work would be appreciated-thanks!

Limit Order

A limit order indicates the highest price you are willing to pay for a security, or the lowest price you are willing to accept to sell a security. Your order will be executed at your designated price or better. This helps protect your order from sudden volatility, but it also means you will only buy or sell the security if it reaches the price you're seeking.

Also, as far as i can tell everytime i make a limit-buy or limit-sell, the money totalling the amount of the transaction is tied up until completion of the buy or sell limit...

Hope this answered your questions...

[blue]

There are two kinds of limit orders--good for the day, and good until cancelled. Good for the day is the usual default, and what most people do, because either your order is filled at your price or better, or not, and you know by the end of the day. You don't tie money up for more than the day. You can always enter another good for the day limit order the next day if your order didn't fill....

[Stealpulse]

CrAzY trading range on this today. I picked some up @ .67 . It's been down to .66 and up to .90 ...sheesh!

[zwaffelaar]

WORCESTER, Mass., June 10, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (:: Generex Biotechnology Corporation ::) today announced that all of the 8% Senior Secured Convertible Notes issued by the Company on March 31, 2008 have been satisfied in full and no longer are outstanding.

As a result of the satisfaction of the notes, $3,000,000 in cash collateral provided as security for the Notes will be returned to the Company.

[victoria]

Originally Posted by fherrada Limit Order A limit order indicates the highest price you are willing to pay for a security, or the lowest price you are willing to accept to sell a security. Your order will be executed at your designated price or better. This helps protect your order from sudden volatility, but it also means you will only buy or sell the security if it reaches the price you're seeking. Also, as far as i can tell everytime i make a limit-buy or limit-sell, the money totalling the amount of the transaction is tied up until completion of the buy or sell limit... Hope this answered your questions...

I appreciate the time! I used a limit/ sell at opening today as ANX was trading up pre-market. The stock immediately began dropping at open, reached my limit price of 0.22-but did not kick in, reached it again-but did not kick in. Luckily there was a brief upswing to .22 for the third hit-and SOLD! Now ANX is floating down for the day, pinging between .19 and .20

Gains and losses on each penny are big , glad I'm paying attention.

Thanks again fherrada, and others...

[victoria]

Originally Posted by zwaffelaar WORCESTER, Mass., June 10, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (:: Generex Biotechnology Corporation ::) today announced that all of the 8% Senior Secured Convertible Notes issued by the Company on March 31, 2008 have been satisfied in full and no longer are outstanding. As a result of the satisfaction of the notes, $3,000,000 in cash collateral provided as security for the Notes will be returned to the Company.

Thanks for the research of encouragement-I was considering grabbing profit and getting out. Like the rest on this board, I have been discovering resistance/impatience-rather than soaring/elation as when it reached $1.00 a week or so ago. Can't remember when as I have been dozing off with this one.

Got in at .50-so think its worth hanging around for a bit.

[zwaffelaar]

Generex's Net Loss Widens On Interest Expense
06/10/09 - 01:28 PM EDT

GNBT TSC Ratings

More on GNBT Generex Posts Net Loss in Second Quarter Market Activity Once these most recent quarterly results are finalized, they will be run through TheStreet.com Ratings' model and our ratings will be adjusted accordingly. To keep up to date on all of our ratings, visit TheStreet.com Ratings Screener. On June 9, 2009, Generex Biotechnology(GNBT Quote) reported that its Q3 FY09 net loss widened on interest expense and the repricing costs of warrants costs issued in connection with convertible debentures, partially offset by a decrease in expenses. Net loss increased to $11.35 million or $0.08 per share from $10.17 million or $0.09 per share a year ago.
Revenue surged to $45,251 from $1,530 in Q3 FY08, reflecting the sales of over-the-counter products and maximum sales from Glucose RapidSpray product. The revenues exclude the amount of deferred sales made to its customers.
Cost of goods sold soared to $26,297 from $639. Research and development expenses fell 30.2% to $3.00 million, reflecting timing differences of the overall increased levels of research and development of the oral insulin product and platform technology in connection with global Phase III clinical trials. Selling and marketing expenses declined 12.3% to $367,371 on commercial sales of over-the-counter products. Despite a marginal increase in legal expenses and financial services, general and administrative costs declined 46.7% to $2.74 million due to a decrease in expenses for consulting and accounting services and falling travel expenses.
Recently, GNBT announced that the Phase I trial for the immunotherapeutic peptide AE37 for prostate cancer was complete and the vaccine is safe and produces the desired immunological response in patients. Additionally, the company launched the commercial retail sales of Generex Oral-lyn, an oral-insulin spray product used in the treatment of diabetes, in Lebanon. Also, Generex Biotechnology received the approval to sell the same product in the Algerian market. The company's subsidiary, Antigen Express, has entered into an agreement with the Immune Tolerance Network for implementing a better diagnostic test for Type-I diabetes. Lastly, the company received a new patent in Morocco.